Company intelligence / Profile preview

Allium

Singapore, Singaporeallium.so ↗

Ownership: Private
Development stage: Commercial

Overview

Allium Bio has developed a functional protein isolate using co-culture fermentation of microalgae and mycelium, designed to replace soy protein and common additives in plant-based meat products. The product offers improved nutrition, sustainability, taste, faster growth rates, lower harvesting costs, and unique functional properties such as emulsification and binding. The company is at seed stage with early investment but no large-scale commercial launch yet.

Modalities: ProteinFermentation-derived ingredient
Industry: Non-Drug Biotech

Partnerships

Proveg Incubator (investor/incubator partnership)Better Bite Ventures (investor/incubator partnership)

Beyond the preview

Go deeper on Allium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allium.

Explore the full profile